Paradoxically, the opposite is observed, with reduced PRL levels observed in some cases of obesity and metabolic disease, suggesting a hypothalamic–pituitary dysfunction might be to blame for the alterations in PRL levels [26,29]. The gene discussed is PRL; the disease is metabolic disease.